Literature DB >> 19454054

Organophosphorus poisoning (acute).

.   

Abstract

INTRODUCTION: Acute organophosphorus poisoning occurs after dermal, respiratory, or oral exposure to either low-volatility pesticides (e.g. chlorpyrifos, dimethoate) or high-volatility nerve gases (e.g. sarin, tabun). Most cases occur in resource-poor countries as a result of occupational or deliberate exposure to organophosphorus pesticides. METHODS AND
OBJECTIVES: We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments for acute organophosphorus poisoning? We searched: Medline, Embase, The Cochrane Library and other important databases up to August 2006 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 22 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: activated charcoal, alpha2 adrenergic receptor agonists, atropine, benzodiazepines, butyrylcholinesterase replacement therapy, cathartics, extracorporeal clearance, gastric lavage, glycopyrronium bromide, ipecacuanha, magnesium sulphate, milk or other home remedies, N-methyl-D-aspartate receptor antagonists, organophosphorus hydrolases, oximes, sodium bicarbonate, washing the poisoned person and removing contaminated clothing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19454054      PMCID: PMC2943818     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  62 in total

1.  Evaluation of two treatment regimens of pralidoxime (1 gm single bolus dose vs 12 gm infusion) in the management of organophosphorus poisoning.

Authors:  S Johnson; J V Peter; K Thomas; L Jeyaseelan; A M Cherian
Journal:  J Assoc Physicians India       Date:  1996-08

Review 2.  Drug interactions with neuromuscular blockers.

Authors:  S Feldman; L Karalliedde
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

3.  Agricultural pesticide use in developing countries: health effects and research needs.

Authors:  C Wesseling; R McConnell; T Partanen; C Hogstedt
Journal:  Int J Health Serv       Date:  1997       Impact factor: 1.663

4.  Incidence of intermediate syndrome in organophosphorous poisoning.

Authors:  J Samuel; K Thomas; L Jeyaseelan; J V Peter; A M Cherian
Journal:  J Assoc Physicians India       Date:  1995-05

5.  Control of blood pressure, heart rate and haematocrit during high-dose intravenous paraoxon exposure in mini pigs.

Authors:  G Petroianu; L M Toomes; A Petroianu; W Bergler; R Rüfer
Journal:  J Appl Toxicol       Date:  1998 Jul-Aug       Impact factor: 3.446

6.  Diazepam as a treatment for nerve agent poisoning in primates.

Authors:  M R Murphy; D W Blick; M A Dunn; J W Fanton; S L Hartgraves
Journal:  Aviat Space Environ Med       Date:  1993-02

Review 7.  Neuropsychopathological changes by organophosphorus compounds--a review.

Authors:  P Eyer
Journal:  Hum Exp Toxicol       Date:  1995-11       Impact factor: 2.903

Review 8.  Misadventures with activated charcoal and recommendations for safe use.

Authors:  L S Mauro; J J Nawarskas; V F Mauro
Journal:  Ann Pharmacother       Date:  1994 Jul-Aug       Impact factor: 3.154

Review 9.  Pharmacokinetics and related pharmacodynamics of anticholinergic drugs.

Authors:  T Ali-Melkkilä; J Kanto; E Iisalo
Journal:  Acta Anaesthesiol Scand       Date:  1993-10       Impact factor: 2.105

10.  Prevention of oral dichlorvos toxicity by different activated charcoal products in mice.

Authors:  Y Tuncok; A Gelal; S Apaydin; H Guven; J Fowler; A Gure
Journal:  Ann Emerg Med       Date:  1995-03       Impact factor: 5.721

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.